Company: SMNR
Filing Date: 2025-08-12
Form Type: S-4/A
Source: 0001193125-25-178821
Chunk: 820

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-12
Form: S-4/A
Chunk 820
---
 |     |   |     (115,384 | ) |     |   |     (110,694 | ) |
| Total stockholders’ deficit                                                                                                                                                                                   |     |   |      (42,784 | ) |     |   |      (38,094 | ) |
| Total liabilities and stockholders’ deficit                                                                                                                                                                   |     | $ |        6,684 |   |     | $ |          703 |   |

See accompanying notes to financial statements F-66

#### SEMNUR PHARMACEUTICALS, INC.STATEMENTS OF OPERATIONS(In thousands, except for share and net loss per share amounts)Year Ended December 31,20242023Operating expenses:Research and development$1,709$1,621General and administrative2,9811,640Total operating expenses4,6903,261Loss from operations(4,690)(3,261)Net loss$(4,690)$(3,261)Net loss per share — basic and diluted$(0.03)$(0.02)Weighted average number of shares during the period — basic and diluted160,000,000160,000,000See accompanying notes to financial statementsF-67
SEMNUR PHARMACEUTICALS, INC. STATEMENTS OF STOCKHOLDERS’ DEFICIT (In thousands, except share amounts)

|                            |     | Common Stock 
 Shares       |             |     | Amount |   |     | Additional 
 Paid-in    
 Capital    |        |     | Accumulated 
 Deficit     |          |   |     | Stockholders’ 
 Deficit       |         |   |
|:---------------------------|:----|:-------------|------------:|:----|:-------|--:|:----|:-----------|-------:|:----|:------------|:---------|:--|:----|:--------------|:--------|:--|
| Balance, December 31, 2022 |     |              | 160,000,000 |     | $      | 2 |     | $          | 72,598 |     | $           | (107,433 | ) |     | $             | (34,833 | ) |
| Net loss                   |     |              |           — |     |        | — |     |            |      — |     |             | (3,261   | ) |     |               | (3,261  | ) |
| Balance, December 31,